BBC documentary about Parkinson's wins award Date 8 Tachwedd 2016 Paul Mayhew-Archer has won an award for his BBC documentary Parkinson's: The Funny side.
New drug treatment Opicapone launches in UK Date 18 Hydref 2016 A new drug treatment for Parkinson's, opicapone, has launched in the UK. It could prolong the effect of levodopa and reduce the number of tablets required.
New research highlights importance of cardiovascular health in Parkinson's Date 29 Medi 2016 New research shows that people recently diagnosed with Parkinson's who are at high or medium risk of cardiovascular disease tend to have more problems with walking and memory.
Study shows potential benefit for caffeine in Parkinson's Date 20 Medi 2016 A new clinical study published in the journal Parkinsonism and Related Disorders links higher caffeine consumption to slower development of Parkinson's symptoms after diagnosis.
Ultrasound treatment shows promise for managing tremor Date 26 Awst 2016 Positive results from a trial of ultrasound therapy for treating tremor have been published, with potential benefits for controlling Parkinson's symptoms.
Could Parkinson's be detected with an eye test? Date 18 Awst 2016 Researchers from the UCL have identified a way to detect Parkinson's through the eyes in a rat model of the condition.
Understanding the link between head injury and Parkinson's risk Date 12 July 2016 New research suggests that severe head injury, which causes loss of consciousness, could be linked to increased risk of developing Parkinson's.
A year on from Duodopa success Date 2 July 2016 A year after Duodopa was funded by NHS England we reflect on the importance of campaigning for people affected by Parkinson's and how you can get involved.
7 major pharma companies sign up to Parkinson's initiative Date 23 Chwefror 2016 7 of the world’s largest pharmaceutical companies have signed up to a ground-breaking new initiative to improve clinical trials for Parkinson's.
Common dementia drug could improve Parkinson's symptoms Date 12 Ionawr 2016 Researchers at the University of Bristol have discovered that a common dementia drug, rivastigmine, could reduce falls in people with Parkinson's.
